Generation and characterisation of an estrogen receptor-positive GEMM-derived Pten p53 null transplantable breast tumour model for therapeutic testing
Davies, E. J.; Morgan, H.; Tornillo, G.; Chabbert, C.; Kendrick, H.; Ahdesmaki, M. J.; Luke, S.; Barry, S. T.; Smalley, M. J.
Show abstract
Assessing the signalling pathway dependencies of tumours that arise autochthonously in genetically engineered mouse models (GEMMs) of breast cancer is particularly challenging due to the high degree of intra- and inter-tumour heterogeneity, as well as the long latency of tumour development in such models. Use of transplantable tumour lines derived from autochthonous tumours ( Mouse Derived Xenografts or MDXs) is one possible solution and has been used successfully in models of BRCA1-associated triple negative breast cancer. However, their potential in ER+ breast cancer models has not been addressed. Here, we assess the utility of orthotopic transplantable tumour lines derived from an autochthonous ER+ Blg-cre Ptenfl/fl p53fl/fl breast cancer model. We show that initial tumour implantation and early passage results in the development of lines of progeny with heterogeneous histopathological phenotypes which is coincident with an accumulation of, or selection for, de novo mutations. Importantly, these lines also display different dependencies on the key pathways that drive tumourigenesis, which can lead to inherent resistance to treatment with pharmacological agents targeting these pathways and makes them important models to test strategies to overcome such resistance.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer 92%
- USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. 92%
- Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies 92%
Similar papers in this journal
- Targeting subtype-specific metabolic preferences in nucleotide biosynthesis inhibits tumor growth in a breast cancer model 94%
- A versatile ES cell-based melanoma mouse modeling platform 92%
- Modeling High-grade serous ovarian carcinoma using a combination of in vivo electroporation and CRISPR/Cas9 mediated genome editing 92%
Similar papers in this journal
- ATRX alteration contributes to tumor growth and immune escape in pleomorphic sarcomas 93%
- Blocking Gi/o-coupled signaling eradicates cancer stem cells and sensitizes breast tumors to HER2-targeted therapies to inhibit tumor relapse 93%
- Promoterless Transposon Mutagenesis Drives Solid Cancers via Tumor Suppressor Inactivation 93%